Table 4.
Engineered zinc alloys with antibacterial properties.
Alloy system | Sample | Preparation | Bacterial strains | Antibacterial test | Antibacterial effect | Antibacterial mechanisms | Application | Reference |
---|---|---|---|---|---|---|---|---|
Zn-Cu | Zn-4.0 wt.%Cu | Extrusion at 280°C | S. aureus | Live/dead cell staining | Effectively inhibited bacteria adhesion and biofilm formation | Release of Cu and Zn ions | Vascular stents | Niu et al., 2016 |
Zn-Cu | Zn-xCu (x=1, 2, 3, and 4 wt%) alloys | Extrusion at 280°C | S. aureus | Inhibition zone diameter (IZD) test | Antibacterial property was perfect when Cu concentration > 2 wt% | Release of Cu and Zn ions | Cardiovascular implants | Tang et al., 2017 |
Zn-Cu | Zn-xCu (x = 1, 2 and 4 wt%) alloys | Casting followed by heating to 350°C for 1 h and rolling | Mixed oral bacteria | Live/dead cell staining | Zn-4Cu alloy can inhibit biofilm formation of mixed oral bacteria | Release of Zn2+ and Cu2+ and increased pH (OH- release) | Osteosynthesis implants, especially in the craniomaxillofacial area | Li et al., 2019b |
Zn-Cu-Fe | Zn-3Cu-xFe (x = 0, 0.2, 0.5 wt%) | Extrusion at 180°C | S. aureus, E. coli | Plate counting | Antibacterial properties of Zn-3Cu alloy were significantly improved by Fe alloying | Higher degradation rate and more Zn2+ and Cu2+ released | Vascular stents | Yue et al., 2020 |
Zn-Cu-Ti | Zn-1Cu-0.1Ti alloy | Casting and plastic deformation processes including hot-rolling and cold-rolling | S. aureus | IZD) | Good antibacterial effect with higher IZD than pure Zn | / | Bone fracture fixation applications such as bone screws and plates of biodegradable implants | Lin et al., 2020 |
Zn-Cu | Zn-xCu (x = 0, 0.5, 1 and 2 wt%) | extruding | S. aureus, S. epidermidis, MRSA, MRSE | Plate counting, live/dead staining, FESEM, TEM, real-time PCR of bacteria-related genes | Prevented bacterial adhesion and biofilm information | Inhibition of expression of genes related to wall synthesis, adhesion, colonization, biofilm formation, autolysis, and secretion of virulence factors in MRSA | Biodegradable orthopedic materials | Qu et al., 2020 |
Zn-2Cu | MRSA | Rat femur intramedullary nail infection prevention model | Significant antibacterial activity against MRSA and reduction of inflammatory toxic side-effects and infection-related bone loss | Qu et al., 2020 | ||||
Zn-Ag | Zn-4.0Ag alloy | Casting followed by thermomechanical treatment | S. gordonii | Crystal violet staining, live/dead cell staining | Effectively inhibited initial bacteria adhesion | Released Zn and Ag ions | Craniomaxillofacial osteosynthesis implants | Li et al., 2018 |
Zn-Ag-Au-V | Zn–2Ag–1.8Au–0.2V (wt.%) alloy | Casting followed by hot-rolling at 200°C and annealing at 390°C for 15 min | S. gordonii | Live/dead cell staining | Reduced plaque formation, inhibited bacterial adhesion and biofilm formation | Degradation products, such as released Zn2+, Ag+, and OH− | Craniomaxillofacial osteosynthesis implants | Li et al., 2019a |
Zn-Mg | Zn-0.02 Mg alloy | Extrusion at 180°C | S. aureus, E. coli | Spread plate assay, live/dead viability assay, SEM | Strong antibacterial effect | Zn2+ damaged bacterial cell membranes and inhibited the multiple bacterial activities, such as nutrient transport and glycolysis | Cardiovascular stents | Lin et al., 2019 |
Zn-Al-Mg | Zn-0.5Al-xMg (x = 0, 0.1, 0.3 and 0.5 wt%) | Casting followed by suitable post-treatment | E. coli | Disc diffusion antibiotic sensitivity testing | Zn-0.5Al-0.5Mg significantly prohibited the growth of E. coli | / | Biodegradable orthopedic materials | Bakhsheshi-Rad et al., 2017 |
Zn-Mg-Sr | Zn-0.8Mg-0.2Sr (wt%) | Combination of casting, homogenization annealing, and extrusion at 200°C | S. gordonii | Live/dead staining | Effective inhibition of initial adhesion and biofilm formation | Released Zn2+ and alkaline shift in pH | Cranial and maxillofacial implants | Capek et al., 2021 |
“/” means “not mentioned”.